These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37121767)
21. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia]. Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329 [No Abstract] [Full Text] [Related]
22. A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation. Kim HJ; Chung IJ; Lee JJ; Seo JS; Park MR; Choi KS; Kook H; Hwang TJ Korean J Intern Med; 1998 Feb; 13(1):60-3. PubMed ID: 9538634 [TBL] [Abstract][Full Text] [Related]
23. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease. Sasaki N; Ishii A; Kurabayashi T; Sugiyama M; Izumi Y; Nakagome Y; Hirano K; Sasaki S; Kondo Y; Nogi S; Nishikawa A; Hosono Y; Yamada C; Sato S Mod Rheumatol Case Rep; 2021 Jan; 5(1):87-94. PubMed ID: 33048020 [TBL] [Abstract][Full Text] [Related]
24. [Successful treatment with prednisolone for air-leak syndrome following interstitial pneumonia after allogeneic hematopoietic stem cell transplantation]. Honda Y; Miyaji R; Morita H; Inagaki J; Kusuhara K Rinsho Ketsueki; 2012 Apr; 53(4):455-9. PubMed ID: 22687980 [TBL] [Abstract][Full Text] [Related]
30. Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE. Deng L; Chen Y; Hu X; Zhou J; Zhang Y Front Immunol; 2021; 12():708463. PubMed ID: 34671344 [TBL] [Abstract][Full Text] [Related]
31. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide. Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S Ann Hematol; 2021 May; 100(5):1295-1301. PubMed ID: 33580280 [TBL] [Abstract][Full Text] [Related]
33. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports. Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468 [TBL] [Abstract][Full Text] [Related]
34. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect. Childs RW; Clave E; Tisdale J; Plante M; Hensel N; Barrett J J Clin Oncol; 1999 Jul; 17(7):2044-9. PubMed ID: 10561256 [TBL] [Abstract][Full Text] [Related]
35. [A case of focal segmental glomerulosclerosis with nephrotic syndrome after hematopoietic stem cell transplantatation for aplastic anemia]. Fuyama M; Ikeda H; Isoyama K Nihon Jinzo Gakkai Shi; 2013; 55(1):83-9. PubMed ID: 23461215 [TBL] [Abstract][Full Text] [Related]
36. Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies. Law AD; Salas MQ; Lam W; Michelis FV; Thyagu S; Kim DDH; Lipton JH; Kumar R; Messner H; Viswabandya A Biol Blood Marrow Transplant; 2018 Nov; 24(11):2259-2264. PubMed ID: 30009980 [TBL] [Abstract][Full Text] [Related]
37. Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors. Brissot E; Labopin M; Moiseev I; Cornelissen JJ; Meijer E; Van Gorkom G; Rovira M; Ciceri F; Griskevicius L; Blaise D; Forcade E; Mistrik M; Mielke S; Bulabois CE; Niittyvuopio R; Deconinck E; Ruggeri A; Sanz J; Spyridonidis A; Savani B; Giebel S; Nagler A; Mohty M J Hematol Oncol; 2020 Jul; 13(1):87. PubMed ID: 32620146 [TBL] [Abstract][Full Text] [Related]
38. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia. Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924 [TBL] [Abstract][Full Text] [Related]
39. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867 [TBL] [Abstract][Full Text] [Related]
40. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]